Abstract:Background: There is currently a lack of convincing evidence for microwave ablation (MWA) and laparoscopic liver resection (LLR) for patients ≥60 years old with 3-5 cm hepatocellular carcinoma (HCC). Materials and Methods: Patients were divided into three cohorts based on restricted cubic spline (RCS) analysis: 60-64, 65-72, and ≥73 years. Propensity score matching (PSM) was performed to balance the baseline variables in a 1:1 ratio. Overall survival (OS) and disease-free survival (DFS) were assessed, followed by a comparison of complications, hospitalization and cost. Results: Among 672 patients, the median age was 66 (IQR 62-71) years. After PSM, two groups of 210 patients each were selected. During the 36.0 (20.4-52.4) month follow-up period, the 1-, 3- and 5-year OS rates in the MWA group were 97.6%, 80.9%, 65.3% and 95.5%, 78.7%, 60.4% in the LLR group (HR 0.98, P =0.900). The corresponding DFS rates were 78.6%, 49.6%, and 37.5% and 82.8%, 67.8%, and 52.9% (HR 1.52, P =0.007). The 60-64 age cohort involved 176 patients, with no a significant difference in OS between the MWA and LLR groups (HR 1.25, P =0.370), MWA was associated with a higher recurrence rate (HR 1.94, P =0.004). A total of 146 patients were matched in the 65-72 age cohort, with no significant differences in OS and DFS between the two groups (OS (HR 1.04, P =0.900), DFS (HR 1.56, P =0.110)). In 76 patients aged ≥73 years after PSM, MWA provided better OS for patients (HR 0.27, P =0.015), and there were no significant differences in DFS between the two groups (HR 1.41, P =0.380). Taken together, for patients older than 65 years, the recurrence rate of MWA was comparable with LLR. Safety analysis indicated that LLR was associated with more postoperative bleeding ( P =0.032) and hypoproteinemia ( P =0.024). Conclusions: MWA was comparable to LLR in patients aged 65 years and older. MWA could be an alternative for the oldest old or the ill patients who cannot afford LLR, while LLR is still the fist option of treatments for early-stage 3-5 cm HCC in capable elderlys.

Laparoscopic Hepatectomy Versus Microwave Ablation for Multifocal 3-5Cm Hepatocellular Carcinoma: a Multi-center, Real-world Study

Microwave Ablation Vs. Surgical Resection for Treatment Naïve Hepatocellular Carcinoma Within the Milan Criteria: a Follow-Up of at Least 5 Years

Comparison of Percutaneous Microwave Ablation and Surgical Resection for Hepatocellular Carcinoma in the Caudate Lobe

Percutaneous Microwave Ablation Versus Robot-Assisted Hepatectomy for Early Hepatocellular Carcinoma: A Real-World Single-Center Study.

Surgical Resection Plus Radiofrequency Ablation for the Treatment of Multifocal Hepatocellular Carcinoma.

Comparison of Cooled-Probe Microwave and Radiofrequency Ablation Treatment in Incipient Hepatocellular Carcinoma: A Phase Iii Randomized Controlled Trial with 6-Year Follow-Up

Long-term Efficacy of Microwave Ablation in the Treatment of Subcapsular Hepatocellular Carcinomas of ≤3 Cm in Diameter: a Multicenter, Propensity Score-Matched Study

MICROWAVE ABLATION VERSUS LAPAROSCOPIC RESECTION AS FIRST-LINE THERAPY FOR SOLITARY 3–5 CM HEPATOCELLULAR CARCINOMA

A multicenter case controlled study on laparoscopic hepatectomy versus microwave ablation as first-line therapy for 3-5 cm hepatocellular carcinoma in patients aged 60 and older

Microwave ablation versus liver resection for primary intrahepatic cholangiocarcinoma within Milan criteria: a long-term multicenter cohort study

Comparison of Microwave Ablation and Transarterial Chemoembolization for Single-Nodule Hepatocellular Carcinoma Smaller Than 5cm: A Propensity Score Matching Analysis.

Liver resection versus microwave ablation for solitary and small (≤ 3 cm) HCC with early recurrence in different stages of liver cirrhosis: A propensity score matching study

Comparison of Parallel and Crossed Placement of Antennas in Microwave Ablation of 3–5 Cm Hepatocellular Carcinoma

Microwave ablation versus laparoscopic resection as first‐line therapy for solitary 3–5‐cm HCC

Percutaneous Microwave Ablation for Hepatocellular Carcinoma Adjacent to Large Vessels: A Long-Term Follow-Up

Learning Curve of Microwave Ablation for Liver Cancers

Microwave ablation shows similar survival outcomes compared with surgical resection for hepatocellular carcinoma between 3 and 5 cm

Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial

Microwave Ablation in Treating Intrahepatic Recurrence of Hepatocellular Carcinoma after Liver Transplantation: an Analysis of 11 Cases

Outcomes of Microwave Ablation for Hepatocellular Carcinoma Adjacent to Large Vessels: a Propensity Score Analysis

Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis